Skip to main content
. 2021 Apr 26;24(3):124–130. doi: 10.1136/ebmental-2021-300254

Table 3.

Facilitators and barriers to mhGAP-IG implementation success identified by qualitative studies

System level Facilitators Barriers
Service user Ability to see traditional healers alongside biomedical care.31
Community awareness raising.32
Cultural differences with the biomedical model.33
Different perspectives on appropriate treatment.34–36
Rural residence, distance from health facilities, thinking that problems will self-resolve, concerns about treatment costs.37
Resistance to treatment.38
Staff Health worker motivation.39
Sharing research findings collaboratively.40
Resistance from faculty members.41
Time constraints and workload.42 43
Stigma.38 39 43
Mistrust of informal health providers, cultural misunderstandings.38
Service Supervision.39 42 44
Onward referral.32
Reliable psychotropic medicine procurement.32 39 44
Trained female community health volunteers.32
Scarcity of specialist staff to deliver supervision.39 45
Lack of financial resources38 41
Limited referral systems.38
Staff turnover, lack of confidential space for consultation.39
Leadership Strong political and organisational support.35 36 39 40 Lack of institutional support.41